Sergio Traversa, Chief Executive Officer at RELMADA THERAPEUTICS, INC. (RLMD), bought 670,000 shares at $0.56 ($335K) on 2025-05-20, disclosed to the SEC on 2025-05-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.45 | 172,314 | $78K | 23.1% |
| 2 | $0.45 | 172,314 | $78K | 23.1% |
| 3 | $0.50 | 30,000 | $15K | 4.5% |
| 4 | $0.56 | 147,686 | $83K | 24.7% |
| 5 | $0.56 | 147,686 | $83K | 24.7% |
| Total | $0.50 avg | 670,000 |
| $335K |
| 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2024-09-11 | $790K | — | Filing → |